650
Participants
Start Date
October 31, 2007
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
TDS-943 (topical diclofenac sodium 4% spray)
celecoxib
placebo
Wallingford
Roanoke
Winston-Salem
Raleigh
Atlanta
Atlanta
Atlanta
Ormond Beach
Jacksonville
DeLand
Pembroke Pines
Tampa
Tampa
Pinellas Park
Ocala
Kissimmee
Stuart
Huntsville
Mobile
Cordova
Memphis
Columbus
Perrysburg
Cincinnati
Evansville
Gurnee
Chicago
Morton
Peoria
Florissant
St Louis
Baton Rouge
Dallas
Dallas
San Antonio
Mesa
Tucson
Tucson
Torrance
Pico Rivera
Santa Barbara
Fair Oaks
Cranston
Lead Sponsor
Mika Pharma GmbH
INDUSTRY